Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Ash Stevens LLC

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Indo Livestock Expo
Not Confirmed
arrow
arrow
Indo Livestock Expo
Not Confirmed

MOBOCERTINIB

NDC Package Code : 48957-0104

Start Marketing Date : 2021-09-15

End Marketing Date : 2026-09-30

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

Looking for 2389149-74-8 / Mobocertinib Succinate API manufacturers, exporters & distributors?

Mobocertinib Succinate manufacturers, exporters & distributors 1

83

PharmaCompass offers a list of Mobocertinib Succinate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mobocertinib Succinate manufacturer or Mobocertinib Succinate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mobocertinib Succinate manufacturer or Mobocertinib Succinate supplier.

PharmaCompass also assists you with knowing the Mobocertinib Succinate API Price utilized in the formulation of products. Mobocertinib Succinate API Price is not always fixed or binding as the Mobocertinib Succinate Price is obtained through a variety of data sources. The Mobocertinib Succinate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Mobocertinib Succinate

Synonyms

2389149-74-8, Mobocertinib (succinate), Tak-788 succinate, Ap32788 succinate, Ap-32788 succinate, 53qia92zee

Cas Number

2389149-74-8

Unique Ingredient Identifier (UNII)

53QIA92ZEE

About Mobocertinib Succinate

MOBOCERTINIB SUCCINATE is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 2021 and is indicated for non-small cell lung carcinoma. This drug has a black box warning from the FDA.

Mobocertinib Succinate Manufacturers

A Mobocertinib Succinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mobocertinib Succinate, including repackagers and relabelers. The FDA regulates Mobocertinib Succinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mobocertinib Succinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Mobocertinib Succinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Mobocertinib Succinate Suppliers

A Mobocertinib Succinate supplier is an individual or a company that provides Mobocertinib Succinate active pharmaceutical ingredient (API) or Mobocertinib Succinate finished formulations upon request. The Mobocertinib Succinate suppliers may include Mobocertinib Succinate API manufacturers, exporters, distributors and traders.

click here to find a list of Mobocertinib Succinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Mobocertinib Succinate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mobocertinib Succinate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Mobocertinib Succinate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Mobocertinib Succinate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Mobocertinib Succinate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mobocertinib Succinate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Mobocertinib Succinate suppliers with NDC on PharmaCompass.

Mobocertinib Succinate Manufacturers | Traders | Suppliers

Mobocertinib Succinate Manufacturers, Traders, Suppliers 1
95

We have 1 companies offering Mobocertinib Succinate

Get in contact with the supplier of your choice:

  1. Ash Stevens
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.